Advertisement
Screener

REVVITY, INC (RVTY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.3 / 5 stars · 54/120 Roast Me

REVVITY, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-01-02 was 263.00K shares, a 32.16% increase year-over-year.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-10-03 was 0.00 shares, a 100.00% decline year-over-year.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-07-04 was 0.00 shares, a 100.00% decline year-over-year.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-04-04 was 96.00K shares, a 357.14% increase year-over-year.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 37.00K shares, a 68.38% decline from fiscal 2024.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 117.00K shares, a 101.72% increase from fiscal 2023.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 58.00K shares, a 70.26% decline from fiscal 2023.
  • REVVITY, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 195.00K shares, a 45.68% decline from fiscal 2022.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2025-12-2837.00K shares
10-K · filed 2026-02-24
2024-12-29117.00K shares
10-K · filed 2025-02-25
2023-12-3158.00K shares
10-K · filed 2024-02-27
2023-01-01195.00K shares
10-K · filed 2023-03-01
2022-01-02263.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
359.00K shares
10-K · filed 2022-03-03
2021-10-030.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
295.00K shares
derived: sum of 4 quarters · filed 2021-11-09
2021-07-040.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
664.00K shares
derived: sum of 4 quarters · filed 2021-08-10
2021-04-0496.00K shares
10-Q · filed 2021-05-11
839.00K shares
derived: sum of 4 quarters · filed 2021-05-11
2021-01-03199.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
764.00K shares
10-K · filed 2021-03-02
2020-10-04369.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
609.00K shares
derived: sum of 4 quarters · filed 2020-11-10
2020-07-05175.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
258.00K shares
derived: sum of 4 quarters · filed 2020-08-11
2020-04-0521.00K shares
10-Q · filed 2020-05-12
250.00K shares
derived: sum of 4 quarters · filed 2020-05-12
2019-12-2944.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
415.00K shares
10-K · filed 2020-02-25
2019-09-2918.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
526.00K shares
derived: sum of 4 quarters · filed 2019-11-05
2019-06-30167.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
868.00K shares
derived: sum of 4 quarters · filed 2019-08-06
2019-03-31186.00K shares
10-Q · filed 2019-05-07
722.00K shares
derived: sum of 4 quarters · filed 2019-05-07
2018-12-30155.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
709.00K shares
10-K · filed 2019-02-26
2018-09-30360.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
678.00K shares
derived: sum of 4 quarters · filed 2018-11-06
2018-07-0121.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
340.00K shares
derived: sum of 4 quarters · filed 2018-08-07
2018-04-01173.00K shares
10-Q · filed 2018-05-08
611.00K shares
derived: sum of 4 quarters · filed 2018-05-08
2017-12-31124.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
578.00K shares
10-K · filed 2018-02-27
2017-10-0122.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
518.00K shares
derived: sum of 4 quarters · filed 2017-11-07
2017-07-02292.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
619.00K shares
derived: sum of 4 quarters · filed 2017-08-08
2017-04-02140.00K shares
10-Q · filed 2017-05-09
655.00K shares
derived: sum of 4 quarters · filed 2017-05-09
2017-01-0164.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
576.00K shares
10-K · filed 2017-02-28
2016-10-02123.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
610.00K shares
derived: sum of 4 quarters · filed 2016-11-08
2016-07-03328.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
510.00K shares
derived: sum of 4 quarters · filed 2016-08-09
2016-04-0361.00K shares
10-Q · filed 2016-05-10
337.00K shares
derived: sum of 4 quarters · filed 2016-05-10
2016-01-0398.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
849.00K shares
10-K · filed 2016-03-01
2015-10-0423.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
886.00K shares
derived: sum of 4 quarters · filed 2016-03-01
2015-06-28155.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
938.00K shares
derived: sum of 4 quarters · filed 2016-03-01
2015-03-29573.00K shares
10-Q · filed 2015-05-05
1.29M shares
derived: sum of 4 quarters · filed 2016-03-01
2014-12-28135.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
1.02M shares
10-K · filed 2016-03-01
2014-09-2875.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
1.11M shares
derived: sum of 4 quarters · filed 2016-03-01
2014-06-29504.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
1.43M shares
derived: sum of 4 quarters · filed 2016-03-01
2014-03-30310.00K shares
10-Q · filed 2014-05-06
1.01M shares
derived: sum of 4 quarters · filed 2016-03-01
2013-12-29226.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
947.00K shares
10-K · filed 2016-03-01
2013-09-29385.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
1.16M shares
derived: sum of 4 quarters · filed 2015-02-24
2013-06-3086.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
1.31M shares
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31250.00K shares
10-Q · filed 2013-05-06
1.34M shares
derived: sum of 4 quarters · filed 2015-02-24
2012-12-30440.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
1.61M shares
10-K · filed 2015-02-24
2012-09-30534.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
1.18M shares
derived: sum of 4 quarters · filed 2014-02-25
2012-07-01116.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
2.90M shares
derived: sum of 4 quarters · filed 2014-02-25
2012-04-01521.00K shares
10-Q · filed 2012-05-08
2012-01-015.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
1.14M shares
10-K · filed 2014-02-25
2011-10-022.26M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
2011-01-021.54M shares
10-K · filed 2013-02-26
2010-01-03459.00K shares
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16